NB

Nadine Brew

Drug Development | R&D | Radiopharmaceuticals | Preclinical Development | Early stage Clinical Trials | University IP commercialisation | VC | Founder | STEM Diversity |

Greater Melbourne Area

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Independent Committee Member

    2024

  • Global Product Development Lead

    2023

    Global lead for PSMA targeting prostate cancer radiopharmaceutical therapeutic, diagnostic and surgery assets. Lead teams totalling 20 biotech executives to rapidly advance development of Telix prostate cancer portfolio programs, TLX592 and TLX599.

  • Co-Founder

    2018

    Lead team of 3 employees to deliver government-funded and industry-partnered STEM board training and leadership program to women and non-binary people around Australia. WILD has a tight knit and highly engaged community with dozens of ambitious senior STEM leaders around Australia.

2023 - 2023

  • Program Director | Oncology

    2023 - 2023

2021 - 2023

  • Operations Manager | RNA | Oncology

    2021 - 2023

    Advance pre-clinical stage long non-coding RNA pipeline of novel therapeutics in range of cancer types. Engage with advisory board and leadership to design and implement high quality drug development program. Target ID, lead optimisation, efficacy, MoA, in vitro and in vivo oncology models.

  • Portfolio Manager | Biotech and Life Sciences VC | Drug Development

    2020 - 2023

    Provide drug development and small biotech operations expertise and services to range of companies in portfolio. Key skills: drug development, R&D study design, oversight planning and management, finance, tax, governance, investor relations, legal, IP.

  • General Manager | Small molecule Pre-clinical Drug Development | Fibrosis

    2020 - 2022

    Collaborate with CSO, scientists and CROs to advance Cincera's drug candidate selection process. Including: toxicity, ADME, PK, safety, potency, mechanism of action, in vitro and in vivo efficacy.

2018 - 2020

  • Global Director Biomedical Research

    2020 - 2020

    Oversight of international portfolio of prostate cancer research programs and clinical trials with wide range of industry, academic, hospital and charity partners.

  • Senior Manager Biomedical Research

    2018 - 2020

2018 - 2018

  • Board Observer

    2018 - 2018

  • Business Development Manager

    2018 - 2018

  • Business Development Officer

    2015 - 2018

    - Identify and evaluate technology transfer opportunities - Analyse market, business and competitive landscape - Produce marketing materials, including presentation and fliers, for opportunities available at the Hudson Institute - Maintain records for patenting and legal costs, intellectual property assets, agreements and commercial relationships - Encourage and capture research invention disclosures - Assist in analysing intellectual property landscape - Identify potential collaboration and development partners - Assist in preparation of funding applications and commercial agreements - Assist with organisation and delivery of monthly Translational Research Workshops